All WebEd times are in EDT
Part One: Marijuana in the Workplace
October 1, 2019
In 33 states the medical use of marijuana has been legalized. Eleven states have passed laws authorizing the personal, adult-use of marijuana and 18 states have authorized the use of CBD. This does not take into account the growing legalization of hemp and hemp-based products such as CBD.
What are the workplace ramifications of this increased use of marijuana and CBD? Are employers limited in taking action against an employee or applicant who claims to use marijuana legally but tests positive for marijuana?
During this webinar, we will provide an overview of the rules state-by-state as they exist today. We will cover the employer limitations and the states where they exist. We will provide suggestions on the steps employers might take to avoid the pitfalls that now exist.
- Review of the current state of medical marijuana.
- Discuss the state law differences.
- Review recent Court decisions.
- Discuss the three key legislative decisions (New York City, Nevada, and Illinois).
Part Two: Cannabidiol (CBD) use in the Workplace
October 8, 2019
What is CBD? How is it different from marijuana? If an employee uses it will they get high? Will they test positive on a workplace drug test? How does the new Farm Bill impact the legalization of CBD?
Eighteen states have authorized the use of cannabidiol - CBD. We will explain what the rules are in these states. We will discuss how and if at all they impact the workplace. We will cover the Farm Bill and the evolving federal government position towards CBD. How does legalizing hemp impact the workplace?
- Explain how CBD differs from Marijuana.
- Does CBD get you high?
- Will CBD cause a positive drug test?
- Discuss Hemp vs. Marijuana.
- Discuss the Farm Bill of 2018 (FDA, States and more).
Part Three: The Opioid Crisis
October 15, 2019
Is there anyone, any workplace that is unaffected by the opioid crisis? According to the latest statistics from the Centers for Disease Control, more than 115 Americans die every day from an opioid overdose. There are enough opioids prescribed every year in this country so that each American, man woman and child could have one.
While marijuana and CBD are the headline-grabbing issues of the day the real threat to business in this country is the opioid crisis. Not only does this crisis impact workplace safety but employers are limited in the actions they can take by the Americans with Disabilities Act and the disability discrimination laws of each state.
We will discuss this issue, providing an overview of the crisis and then diving into the limitations these federal and state laws provide. We will take a hard look at the steps employers should be taking to protect themselves but because they are simply unaware are not.
- Is Opioids more dangerous than the marijuana issue.
- Discuss statistics (understanding the magnitude of the problem).
- Discuss ADA and Opioid issues.
- Discuss the State disability discrimination impact.
William J. Judge, JD, LL.M.
Drug Screening Compliance Institute
Bill is an attorney with over 33 years of experience in the workplace drug and alcohol testing industry and the Co-Founder of Drug Screening Compliance Institute (DSCI) focusing on state, federal and subject-specific compliance training, education and consulting. He is a past Co-Chairman of the Illinois State Chamber of Commerce Drug-Free Workplace Program, a 10-year member of the American College of Occupational and Environmental Medicine (ACOEM) MRO Faculty, a past advisor to the American Society of Addiction Medicine (ASAM) MRO Committee, A 5-year participant in the White House Office of National Drug Control Policy (ONDCP) Regional Student Drug Testing Summits, and a participant in the 1988 White House Conference for a Drug Free America.
Bill has been involved in many workplace drug testing court cases at all levels, including the 1989 United States Supreme Court decision, Railway Labor Executives’ Association v. Skinner. Bill has edited and written numerous articles and publications, including a reference manual for the motor carrier industry entitled, “Drug Testing: Motor Carrier Compliance Manual,” published by J.J. Keller & Associates, “Omnidex,” “Part 40 Merged,” and co-authored with attorney Tommy Eden, “Doing It Right: DRUG FREE SCHOOL TESTING.” Bill co-founded InfoLab, Inc. and managed Workplace Health Co-Op, a substance abuse program administrator. During his tenure with Info-Lab, Inc., he co-owned and operated Info-Meth, a DHHS-certified laboratory located in Peoria, IL.
Bill regularly shares his industry expertise & thought leadership at several local, regional and national speaking events such as DATIA, SAPAA, SHRM & NAPBS.
Everyone who registers for an AGC WebEd will receive a link with access to the audio recording and the presentation.
AGC of America uses Go-To-Meetings to conduct WebEd. You will not incur any cost for using the platform. However, if you have not used this platform previously, please test your computer prior to the WebEd. You may be required to download software, i.e., Java and may need administrative rights to your computer. For computer specifications, please visit https://www.gotomeeting.com/meeting/online-meeting-support or contact email@example.com.
AGC of America WebEd Cancellation & Refund Policy:
If you will not be able to attend an AGC of America WebEd program for which you have already registered, you may qualify for a refund of your registration fee or be able to substitute another employee within your organization. If you cancel your registration at least ten (10) days prior to the webinar, AGC of America will provide a full refund. No refund will be provided if you do not meet this deadline, however you may transfer your registration to another employee within your organization. AGC of America will provide all registrants with a recording of the webinar and the PowerPoint slides following the program.
Any questions or changes to your registration should be made via email to firstname.lastname@example.org.